Mastering The Complexity Of CGT Process Development - How To Meet Challenges On The Path To Commercialization

Bringing cell and gene therapy (CGT) products to market is fraught with complexities and obstacles. In a recent roundtable discussion, leading industry experts delved into the myriad challenges faced in CGT process development and manufacturing. They explored essential aspects such as scalability, process optimization, automation, compliance, and quality assurance. The importance of scalability is to ensure that CGT products can be produced in sufficient quantities to meet market demand, while process optimization is a critical factor in enhancing efficiency and reducing costs. Automation emerged as a key theme, with the experts emphasizing its role in streamlining operations and minimizing human error. 

Watch to receive a wealth of knowledge and practical advice for your biotech company to bring innovative CGT products to market successfully.